Why not to screen high-risk women anticipating BRCA1/BRCA2 testing for psychological distress

Journal of Consulting and Clinical Psychology

Volumn 70, Issue 1, 2002, Pages 258-

  Benazon, Nili R ^a   Coyne, James C ^b   Calzone, Kathleen A ^b   Weber, Barbara L ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; DISTRESS SYNDROME; FAMILIAL CANCER; FEMALE; HIGH RISK PATIENT; HUMAN; LETTER; OVARY CANCER; PSYCHOLOGICAL ASPECT;

ADULT; ATTITUDE TO HEALTH; BREAST NEOPLASMS; DEPRESSIVE DISORDER; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; OVARIAN NEOPLASMS;

EID: 0036172469     PISSN: 0022006X     EISSN: None     Source Type: Journal    
DOI: 10.1037/0022-006X.70.1.258     Document Type: Letter

References (7)

1. Psychological consequences of predictive genetic testing: A systematic review
2. Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families
3. Should we screen for depression? Caveats and pitfalls
4. Routinely administered questionnaires for depression and anxiety: Systematic review
5. Preliminary guidelines for the treatment of distress (11 A-NCCN Proceedings)
6. Breast cancer after prophylactic bilateral mastectomy in women with BRCA1 or BRCA2 mutation
7. Screening and treatment of distress